Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment

Podobne zapisy

• Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
  od: Mitchell Salke, i wsp.
  Wydane: (2025-06-01)
• Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis
  od: Khaled Aldhuaina, i wsp.
  Wydane: (2025-10-01)
• Systematic Review of Efficacy and Safety of Avacopan in Real-World Clinical Practice
  od: Ilay Berke, i wsp.
  Wydane: (2026-04-01)
• Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
  od: Reza Zonozi, i wsp.
  Wydane: (2024-06-01)
• Complement Inhibition in ANCA-Associated Vasculitis
  od: Vladimir Tesar, i wsp.
  Wydane: (2022-07-01)